Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Select Medical Holdings (SEM) over the last 16 years, with Q3 2025 value amounting to $34.4 million.

  • Select Medical Holdings' Depreciation & Amortization (CF) fell 3131.24% to $34.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.8 million, marking a year-over-year decrease of 2936.53%. This contributed to the annual value of $203.9 million for FY2024, which is 232.25% down from last year.
  • Latest data reveals that Select Medical Holdings reported Depreciation & Amortization (CF) of $34.4 million as of Q3 2025, which was down 3131.24% from $34.8 million recorded in Q2 2025.
  • Select Medical Holdings' Depreciation & Amortization (CF)'s 5-year high stood at $54.1 million during Q1 2024, with a 5-year trough of $34.4 million in Q3 2025.
  • In the last 5 years, Select Medical Holdings' Depreciation & Amortization (CF) had a median value of $51.0 million in 2022 and averaged $48.7 million.
  • In the last 5 years, Select Medical Holdings' Depreciation & Amortization (CF) skyrocketed by 800.98% in 2024 and then plummeted by 3562.3% in 2025.
  • Quarter analysis of 5 years shows Select Medical Holdings' Depreciation & Amortization (CF) stood at $51.9 million in 2021, then increased by 0.58% to $52.2 million in 2022, then grew by 3.33% to $54.0 million in 2023, then decreased by 15.27% to $45.7 million in 2024, then dropped by 24.71% to $34.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $34.4 million in Q3 2025, compared to $34.8 million in Q2 2025 and $34.8 million in Q1 2025.